Your Partner in Innovative Healthcare Solutions
At Shafie Darou Aria, we are driven by a passion for transforming lives through groundbreaking pharmaceutical advancements. With a steadfast commitment to quality, innovation, and expertise, we strive to provide cutting-edge solutions that improve public health and enhance the well-being of patients worldwide
About Shafie Darou Aria
Established in 2020, Shafie Darou Aria is a leading pharmaceutical company specializing in the development, production, and export of active pharmaceutical ingredients (APIs) and injectable drug formulations. Our journey began with a vision to leverage the power of knowledge and experience to deliver high-quality products that make a meaningful difference in people’s lives.
OUR VISION
Our vision is to achieve the highest rank in the development, production, and export of contrast drugs in the region within the next five years, solidifying our position as a leading and innovative company that contributes to the independence of Iran's pharmaceutical industry
OUR MISSION
Our mission is to foster self-confidence, trust in knowledge, and commitment among our young workforce, while continuously developing our expertise based on the latest pharmaceutical technologies to improve public health
Driving Innovation Through Continuous Research
Our team of skilled researchers and scientists are constantly exploring new frontiers in pharmaceutical science, leveraging advanced technologies and cutting-edge methodologies to develop innovative solutions that address unmet medical needs. We are committed to investing in research and development to stay at the forefront of the industry and deliver groundbreaking therapies that improve lives.
Our Guiding Principles
Commitment to sustainability and environmental responsibility
Continuous innovation and adherence to the highest ethical standards
Improving the quality of life and increasing hope and longevity for patients
Excellence in product quality, cutting-edge technologies, and exceptional workforce
DotaScan
DotaScan is a gadolinium-based contrast agent designed for intravenous diagnostic use during magnetic resonance imaging (MRI) investigations. It helps visualize areas with disruption of the blood-brain barrier or abnormal vascularity in cranial, cerebral, spinal, and non-coronary arterial diseases in adults and pediatrics.
- Clear, colorless to yellow, aqueous solution containing gadoterate meglumine
- Same active ingredient and relaxivity as Gadoterate brand innovator
- Intended for intravenous bolus injection or power injector
- Recommended dose: 0.2 ml/kg (0.1 mmol/kg) body weight
- Available in vials for adult and pediatric patients
Unwavering Commitment to Quality
At Shafie Darou Aria, we are dedicated to upholding the highest standards of quality in every aspect of our operations. From raw material sourcing to manufacturing processes and final product testing, we employ rigorous quality control measures to ensure the safety, efficacy, and consistency of our pharmaceutical solutions.
Latest published
Stay updated with our latest research findings, industry news, and expert insights.”
